Memantine normalizes brain activity in the inferior frontal gyrus: a controlled pilot fMRI study.
Cerullo
Michael A
MA
Adler
Caleb M
CM
Strakowski
Stephen M
SM
Eliassen
James C
JC
Nasrallah
Henry A
HA
Nasrallah
Amelia T
AT
D000328:Adult; D014150:Antipsychotic Agents / Q000627:therapeutic use; D004292:Dominance, Cerebral / Q000502:physiology; D015259:Dopamine Agents / Q000627:therapeutic use*; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D018691:Excitatory Amino Acid Antagonists / Q000627:therapeutic use*; D005260:Female; D005625:Frontal Lobe / Q000187:drug effects* / Q000473:pathology; D006801:Humans; D007091:Image Processing, Computer-Assisted; D008279:Magnetic Resonance Imaging; D008297:Male; D008559:Memantine / Q000627:therapeutic use*; D011939:Mental Recall / Q000187:drug effects / Q000502:physiology; D010296:Parietal Lobe / Q000187:drug effects; D010865:Pilot Projects; D012559:Schizophrenia / Q000175:diagnosis / Q000188:drug therapy*
D014150:Antipsychotic Agents; D015259:Dopamine Agents; D018691:Excitatory Amino Acid Antagonists; D008559:Memantine